EXTENDING TIME TO DISEASE PROGRESSION OR SURVIVAL IN CANCER PATIENTS
摘要
<p>THE PRESENT APPLICATION DESCRIBES EXTENDING TIME TO DISEASE PROGRESSION OR SURVIVAL IN A CANCER PATIENT, WHERE THE PATIENT'S CANCER DISPLAYS HER ACTIVATION, BY TREATING THE PATIENT WITH A HER DIMERIZATION INHIBITOR, SUCH AS PERTUZUMAB.</p>
